Supplementary Figure S11 from Combining Brigatinib with mTOR Inhibition to Effectively Treat NF2-SWN–Associated and Sporadic NF2-Deficient Meningiomas
Abstract
Figure S11. The brigatinib+INK128 combination more effectively shrank intracranial AG.
Fields of Study & Subjects
Meningioma and schwannoma management
Neurofibromatosis and Schwannoma Cases
Glioma Diagnosis and Treatment
Publication details
- Publication date
- 27 January 2026